Recently, Neuralink, a brain-computer interface startup company owned by Musk, announced that the company has been approved by an independent review committee and will conduct the first human trial to implant brain devices for paralyzed patients
Neuralink announced that the goal of the study is to test the safety and effectiveness of Neuralink’s wireless fully implantable brain-computer interface to enable paralyzed patients to control external devices through their brains. The company has officially begun recruiting clinical trial patients, and eligible paralyzed patients with cervical spinal cord injuries or amyotrophic lateral sclerosis (ALS) can participate in the trial
According to Neuralink’s announcement, this human trial will last for six years. Participants will first participate in an 18-month study and then spend at least two hours a week conducting research on brain-computer interfaces
Neuralink, a brain-computer interface startup owned by Musk, received human clinical trial approval from the U.S. Food and Drug Administration (FDA) in May this year. The company will conduct trials using brain implants and surgical robots. According to Musk, Neuralink's devices can convert brain signals into actions. They will first focus on two application areas: one is to restore human vision, and the other is to help people who cannot move muscles control devices such as smartphones, and even restore damaged spinal cords. The patient’s whole body functions
Musk once said that Neuralink’s short-term goal is to help paralyzed people realize the function of thought typing. In the future, it will also be able to allow paralyzed people to walk, let the blind see, and ultimately realize a "human-computer symbiosis."
The above is the detailed content of Musk's 'brain-computer interface” company takes new steps: first human trial is about to begin. For more information, please follow other related articles on the PHP Chinese website!